A new study funded by PhRMA says the increasing use of authorized generics by drug companies has not led to delays in generic entry into the marketplace.

The US Dept. of Justice (DOJ) Wednesday said that Bristol-Myers Squibb (BMS) has entered guilty pleas to two counts of making false statements to a government agency and will pay the maximum $1 million criminal fine for lying about its Plavix deal with Canadian generics drugmaker Apotex.

Bill Kennally’s job is to keep other generics companies from eating Pfizer’s lunch—or the leftovers thereof.

The FDA launched a Web site warning of the dangers of purchasing Roche’s acne drug Accutane (isotretinoin) or any of its generic equivalents over the Internet.

How will generic erosion to prescription drug brands (such as Zoloft, Zocor, Pravachol)—as well as generic threats (Plavix and Norvasc)—affect spending on direct-to-consumer advertising?

Cracking the patient-physician interaction has long proved elusive for pharma. But by combining patient chart data with actual audio conversations, marketers can better understand how to impact the exchange, says Carolyn Choh Fleming

The Senate Judiciary Committee has approved the Preserve Access to Affordable Generics Act, sponsored by Herb Kohl (D-WI), that would prohibit innovator drug companies from compensating generic drug companies to delay a generic drug’s entry into the market.